Status Approved
First Submitted Date
2020/05/27
Registered Date
2020/07/06
Last Updated Date
2020/07/03
CRIS Required
WHO ICTRP (International Clinical Trial Registry Platform) Required
1. Background
CRIS Registration Number |
KCT0005201 |
---|---|
Unique Protocol ID | DUIH 2020-05-010 |
Public/Brief Title | Epidemiology of Non-Steroidal Anti-inflammatory Drug enteropathy : nationwide population study |
Scientific Title | Epidemiology of NonSteroidal Anti-Inflammatory Drugs (NSAIDs) associated small bowel injuries and Protective effect of mucosa protecting agents against NSAIDs associated small bowel injuries: A cohort study based upon Korean National Health Insurance Service claim database. |
Acronym | |
MFDS Regulated Study | No |
IND/IDE Protocol | No |
Registered at Other Registry | No |
Healthcare Benefit Approval Status | Not applicable |
2. Institutional Review Board / Ethics Committee
Board Approval Status | Submitted exempt |
---|---|
Board Approval Number | DUIH 2020-05-010 |
Approval Date | 2020-05-25 |
Institutional Review Board Name | Dongguk University Ilsan Hospital IRB |
Institutional Review Board Address | 27, Dongguk-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do |
Institutional Review Board Telephone | 031-961-8405 |
Data Monitoring Committee | No |
3. Contact Details
Contact Person for Principal Investigator / Scientific Queries | |
---|---|
Name | yun jeong LIM |
Title | professor |
Telephone | +82-31-961-7133 |
Affiliation | Dongguk University Ilsan Hospital |
Address | 27 Donggukro ilsan- donggu |
Contact Person for Public Queries | |
Name | yun jeong LIM |
Title | professor |
Telephone | +82-31-961-5756 |
Affiliation | Dongguk University Ilsan Hospital |
Address | 27 Donggukro ilsan- donggu |
Contact Person for Updating Information | |
Name | yun jeong LIM |
Title | professor |
Telephone | +82-31-961-5756 |
Affiliation | Dongguk University Ilsan Hospital |
Address | 27 Donggukro ilsan- donggu |
4. Status
Study Site | Multi-center Number of center : 2 | |
---|---|---|
Overall Recruitment Status | Not yet recruiting | |
Date of First Enrollment | 2020-07-06 Anticipated | |
Target Number of Participant | 10000 | |
Primary Completion Date | 2020-09-30 , Anticipated | |
Study Completion Date | 2020-12-31 , Anticipated | |
Recruitment Status by Participating Study Site 1 | ||
Name of Study | Dongguk University Ilsan Hospital | |
Recruitment Status | Not yet recruiting | |
Date of First Enrollment | 2020-07-06 , | |
Recruitment Status by Participating Study Site 2 | ||
Name of Study | Kyungpook National University Medical Center | |
Recruitment Status | Not yet recruiting | |
Date of First Enrollment | 2020-07-06 , |
5. Source of Monetary / Material Support
1. Source of Monetary/Material Support | |
---|---|
Organization Name | Dong-A ST |
Organization Type | Pharmaceutical Company |
Project ID |
6. Sponsor Organization
1. Sponsor Organization | |
---|---|
Organization Name | Dongguk University Ilsan Hospital |
Organization Type | Medical Institute |
7. Study Summary
Lay Summary | The aim is to identify the relation between Non-Steroidal Anti-inflammatory Drug-associated small bowel injury and mucosa-protecting agent. The background is that there is little evidence on the effect of mucosa-protecting agent in the Non-Steroidal Anti-inflammatory Drug associated small bowel injury. The hypothesis is that mucosa-protecting agent can lower the risk of Non-Steroidal Anti-inflammatory Drug-associated small bowel injury. The plan for this clinical study is that firstly, based on NHIS claim data, to find the patient who underwent small bowel capsule endoscopy, and to find out the patient who took Non-Steroidal Anti-inflammatory Drug and mucosa-protecting agent. Based on these, we will identify the relation between Non-Steroidal Anti-inflammatory Drug-associated small bowel injury and mucosa-protecting agent. |
---|
8. Study Design
Study Type | Observational Study |
---|---|
Observational Study Model | Cohort |
Time Perspective | Retrospective |
Target Number of Participant | 10000 |
Cohort/Group Number | 1 |
Cohort/ Group 1 |
Cohort/Group Label patients with Non-Steroidal Anti-inflammatory Drug-associated small bowel injury |
Cohort/Group Description investigate patients with Non-Steroidal Anti-inflammatory Drug-associated small bowel injury and patients who underwent small bowel capsule endoscopy Collect the group of small intestine bleeding lesions observed in the small intestine capsule endoscopy and investigate the medication history. Match the age, sex, medication history, and past medical history of the collected observation group and set the control number 2-3 times. Based on data from national health insurance service, data was extracted using keywords. After close communication with the responsible research team (Gastroenterologist), an experienced big data research institute will extract data and perform statistical analysis |
|
Biospecimen Collection & Archiving |
Not collect nor Archive |
Biospecimen Description |
9. Subject Eligibility
Study Population Description | In the NHIS claim data, pateints who underwent small bowel capsule endoscopy and took Non-Steroidal Anti-inflammatory Drug. |
---|---|
Sampling Method | non-probability sampling :: To ask national health insurance service for the data on the pateints who underwent small bowel capsule endoscopy and took Non-Steroidal Anti-inflammatory Drug, collection of data regarding duration of usage of aspirin, Non-Steroidal Anti-inflammatory Drug, Aspirin and proton pump inhibitor. |
Condition(s)/Problem(s) |
(K00-K93)Diseases of the digestive system
Non-Steroidal Anti-inflammatory Drug-associated small bowel injury |
Rare Disease | No |
Inclusion Criteria |
Gender Both |
Age No Limit~No Limit |
|
Description small bowel ulcer small bowel bleeding iron deficiency anemia hematochezia |
|
Exclusion Criteria |
patient who did not take Non-Steroidal Anti-inflammatory Drug patient who did not take mucosa-protecting agent |
Healthy Volunteers | No |
10. Outcome Measure(s)
Type of Primary Outcome | Efficacy | |
---|---|---|
Primary Outcome(s) 1 | ||
Outcome | incidence rate of Non-Steroidal Anti-inflammatory Drug-associated small bowel injury in patient who took and did not take mucosa-protecting agent |
|
Timepoint | 2020-11 |
|
Secondary Outcome(s) 1 | ||
Outcome | the kind of mucosa-protecting agents |
|
Timepoint | 2020-11 |
11. Study Results and Publication
Result Registered | No |
---|
12. Sharing of Study Data(Deidentified Individual-Patient Data, IPD)
Sharing Statement | No |
---|
TOP
BOTTOM
화면 최하단으로 이동